Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Muge Serhatl"'
Autor:
Ayca Yildiz Pekoz, Ozlem Akbal Dagistan, Hanan Fael, Meltem Culha, Aybige Erturk, Nur Sena Basarir, Gokben Sahin, Muge Serhatli, Gamze Cakirca, Saban Tekin, Leyla Semiha Sen, Mustafa Sevim, Lutfiye Mulazimoglu Durmusoglu, Berrak C. Yegen
Publikováno v:
Drug Delivery, Vol 29, Iss 1, Pp 2846-2854 (2022)
Favipiravir, an RNA-dependent RNA polymerase (RdRp) inhibitor, is used to treat patients infected with influenza virus and most recently with SARS-CoV-2. However, poor accumulation of favipiravir in lung tissue following oral administration has requi
Externí odkaz:
https://doaj.org/article/bdfea95241b44c239c118b5475ad3aa0
Autor:
Öznur Karaoğlu, Müge Serhatlı, Ebru Pelvan, Bülent Karadeniz, Ilknur Demirtas, Gamze Çakırca, Hande Sipahi, Yağmur Özhan, Gözdem Karapınar, Mohammad Charehsaz, Ahmet Aydın, Erdem Yesilada, Cesarettin Alasalvar
Publikováno v:
Journal of Functional Foods, Vol 105, Iss , Pp 105544- (2023)
Prevention of COVID-19 is of paramount importance for public health. Some natural extracts might have the potential to suppress COVID-19 infection. Therefore, this study aimed to design a standardised, efficient, and safe chewable tablet formulation
Externí odkaz:
https://doaj.org/article/f14f412ead4744c49d140cb5e4207939
Autor:
Ebru Pelvan, Müge Serhatlı, Öznur Karaoğlu, Bülent Karadeniz, Ceyda Pembeci Kodolbaş, Neşe Aslı Öncü, Gamze Çakırca, Emel Damarlı, Günay Başdoğan, Gizem Mergen Duymaz, İsmail Emir Akyıldız, Gamze Düz, Sezer Acar, Yağmur Özhan, Hande Sipahi, Mohammad Charehsaz, Ahmet Aydın, Erdem Yesilada, Cesarettin Alasalvar
Publikováno v:
Journal of Functional Foods, Vol 97, Iss , Pp 105225- (2022)
A broad range of evidence has confirmed that natural products and essential oils might have the potential to suppress COVID-19 infection. Therefore, this study aimed to develop an oral/throat spray formulation for prophylactic use in the oral cavity
Externí odkaz:
https://doaj.org/article/6f7bd46f4739498b98e62909c7bf513a
Autor:
Neslihan Pakize Taşlı, Zeynep Burçin Gönen, Oğuz Kaan Kırbaş, Nur Seda Gökdemir, Batuhan Turhan Bozkurt, Buse Bayrakcı, Derya Sağraç, Ezgi Taşkan, Sevda Demir, Nur Ekimci Gürcan, Melike Bayındır Bilgiç, Ömer Faruk Bayrak, Hazel Yetişkin, Büşra Kaplan, Shaikh Terkıs Islam Pavel, Gökçen Dinç, Müge Serhatlı, Gamze Çakırca, Ahmet Eken, Vedat Aslan, Mehmet Yay, Musa Karakukcu, Ekrem Unal, Fethi Gül, Kemal Erdem Basaran, Yusuf Ozkul, Fikrettin Şahin, Olcay Y. Jones, Şaban Tekin, Aykut Özdarendeli, Mustafa Cetin
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
The scale of the COVID-19 pandemic forced urgent measures for the development of new therapeutics. One of these strategies is the use of convalescent plasma (CP) as a conventional source for passive immunity. Recently, there has been interest in CP-d
Externí odkaz:
https://doaj.org/article/29030acd84a84397aaf33a65520ad6ba
Publikováno v:
2017 21st National Biomedical Engineering Meeting (BIYOMUT).
It is known that the cancer cells rapidly proliferate, as the epidermal growth factor receptor (EGFR) is overexpressed on the cell surface. EGFR is a tyrosine kinase receptor and by binding the epidermal growth factor (EGF) certain proteins are activ